Refreshing results…
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Download from doi.orgLow rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
Download from doi.orgTCR β chain–directed bispecific antibodies for the treatment of T cell cancers
UploadMissing publications? Search for publications with a matching author name.